MedTrace Logo

Plasma EBV DNA Monitoring in Post-treatment NPC Patients

NCT03973723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 441

Last updated 2019-06-07

No results posted yet for this study

Summary

Continuous regular monitoring of plasma EBV DNA in nasopharyngeal carcinoma (NPC) after treatment have rarely been investigated. The investigators try to analyze the long-term observational results (role in early relapse detection and impact on survival) in NPC patients after curative treatment.

Conditions

  • Nasopharyngeal Carcinoma
  • NPC
  • EBV
  • Radiotherapy

Sponsors & Collaborators

  • Taichung Veterans General Hospital

    lead OTHER

Principal Investigators

  • Jin-Ching Lin, M.D.,PhD · Taichung Veterans General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-01
Primary Completion
2013-12-31
Completion
2019-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03973723 on ClinicalTrials.gov